Vaccines
Latest News
CDC chief overrules panel, OKs boosters for health care workers
Panelists “did not buy the need in occupational or institutional settings.”
Latest News
COVID-19 vaccines in pregnancy may protect baby, too
“The presence of these anti-spike antibodies in the cord blood should, at least in theory, offer these newborns some degree of protection,” a...
News
FDA OKs Pfizer COVID booster for 65 and over, those at high risk
Emerging evidence shows that booster doses of the Pfizer vaccine cause front-line immune defenders — called binding antibodies — to roughly triple...
News from the FDA/CDC
HPV vaccine safety concerns up 80% from 2015 to 2018
The mismatch between increasing vaccine safety concerns and decreasing adverse events suggests that disinformation may be driving these concerns...
ID Consult
Adolescent immunizations and protecting our children from COVID-19
Now, we have another adolescent vaccine to discuss and encourage our patients to receive.
Latest News
COVID vaccine is safe, effective for children aged 5-11, Pfizer says
A lower dose of the vaccine – just 10 mg – has been tested in children between the ages of 5 and 11.
News
FDA panel backs Pfizer's COVID booster for 65 and older, those at high risk
This followed an earlier 16-2 vote by the panel rejecting a booster dose for Americans age 16 and over.
Letters from Maine
Pandemic goal deficiency disorder
Articulating a national goal that covers both communities where the response to the pandemic has been less thoughtful and robust along with states...
Latest News
New Moderna vaccine data ‘support’ booster shot after 8 months
There is still a lot of debate in the medical community about the need for boosters.
Feature
COVID vaccine preprint study prompts Twitter outrage
The authors’ conclusions about rates of myocarditis after COVID vaccine in boys aged 12-17 years are attacked for supposedly stoking antivaccine...
Latest News
FDA could authorize COVID-19 vaccine for ages 5-11 in October
The agency said it would consider applications for emergency use, which would allow for faster approval.